Bethesda, MD-Mutations in the gene encoding 2-5-oligoadenylate(2-5A)-dependentRNase L (RNASEL) have been found to be associated with prostate cancer inmembers of high-risk families. The recently published research comes frominvestigators from the National Institutes of Health's National Human GenomeResearch Institute and collaborators from industry and several other publicand private institutions.
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
UK study of AI-based software for prostate cancer detection expands
July 22nd 2024"We will be looking not only at how well this software performs in a busy clinical setting and whether diagnostic accuracy and efficiency improves, but also assessing the experience of clinicians and patients, and looking at the impact on workflow," says Clare Verrill, BM, FRCPath, MMedEd.